Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-16 13:22:34 UTC |
---|
Update Date | 2022-03-07 02:49:09 UTC |
---|
HMDB ID | HMDB0001333 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Manganese |
---|
Description | Manganese is an essential trace nutrient in all forms of life. Physiologically, it. exists as an ion in the body. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. |
---|
Structure | |
---|
Synonyms | Value | Source |
---|
MANGANESE (II) ion | ChEBI | Manganese(II) | ChEBI | Manganese, ion (MN2+) | ChEBI | Manganous ion | ChEBI | MN(II) | ChEBI | MN(2+) | ChEBI | MN2+ | ChEBI |
|
---|
Chemical Formula | Mn |
---|
Average Molecular Weight | 54.938 |
---|
Monoisotopic Molecular Weight | 54.938049636 |
---|
IUPAC Name | manganese(2+) ion |
---|
Traditional Name | manganese(2+) ion |
---|
CAS Registry Number | 7439-96-5 |
---|
SMILES | [Mn++] |
---|
InChI Identifier | InChI=1S/Mn/q+2 |
---|
InChI Key | WAEMQWOKJMHJLA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of inorganic compounds known as homogeneous transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a transition metal atom. |
---|
Kingdom | Inorganic compounds |
---|
Super Class | Homogeneous metal compounds |
---|
Class | Homogeneous transition metal compounds |
---|
Sub Class | Not Available |
---|
Direct Parent | Homogeneous transition metal compounds |
---|
Alternative Parents | Not Available |
---|
Substituents | - Homogeneous transition metal
|
---|
Molecular Framework | Not Available |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 1244 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Kovats Retention IndicesUnderivatized |
---|
Spectra |
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Manganese 10V, Positive-QTOF | splash10-0a4i-9000000000-6f3891a406ae3fe4f883 | 2015-09-14 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Manganese 20V, Positive-QTOF | splash10-0a4i-9000000000-6f3891a406ae3fe4f883 | 2015-09-14 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Manganese 40V, Positive-QTOF | splash10-0a4i-9000000000-6f3891a406ae3fe4f883 | 2015-09-14 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Manganese 10V, Negative-QTOF | splash10-0udi-9000000000-c3110d268939143a5f80 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Manganese 20V, Negative-QTOF | splash10-0udi-9000000000-c3110d268939143a5f80 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Manganese 40V, Negative-QTOF | splash10-0udi-9000000000-c3110d268939143a5f80 | 2015-09-15 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
---|
Tissue Locations | - Basal Ganglia
- Brain
- Hair
- Liver
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.0070 - 0.0190 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.18858(0.18020-0.19659) uM | Not Available | Both | Normal | | details | Blood | Detected and Quantified | 0.17292(0.16382-0.18202) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.012 +/- 0.0044 uM | Elderly (>65 years old) | Both | Normal | | details | Blood | Detected and Quantified | <0.320 uM | Children (1-13 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.0730-0.325 uM | Children (1-13 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.01 (0.007 - 0.019) uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0218 +/- 0.0309 uM | Elderly (>65 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.149 +/- 0.177 uM | Adult (>18 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.021 (0.015 - 0.027) uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.292 +/- 0.18 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.0535 +/- 0.0513 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.0411 +/- 0.0346 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.0579 +/- 0.0368 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.0619 +/- 0.0431 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 36.223 +/- 37.133 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 25.483 +/- 30.762 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.109 +/- 0.0546 uM | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.00058 (0.00023-0.00101) umol/mmol creatinine | Not Available | Both | Normal | | details | Urine | Detected and Quantified | 0.00043 (0.00029-0.00056) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.013 (0.002-0.051) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.011 (0.0-0.023) umol/mmol creatinine | Adult (>18 years old) | Male | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | Urine | Detected and Quantified | 0.095 (0-0.053) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 3.48 uM | Children (1-13 years old) | Male | Hypermanganesemia with dystonia 1 | | details | Blood | Detected and Quantified | 0.15 +/- .072 uM | Adult (>18 years old) | Both | Multiple sclerosis | | details | Blood | Detected and Quantified | 0.012 +/- 0.0044 uM | Adult (>18 years old) | Both | Parkinson's disease | | details | Blood | Detected and Quantified | 3.285 uM | Children (1-13 years old) | Female | Hypermanganesemia with dystonia 1 | | details | Blood | Detected and Quantified | 1.511-14.973 uM | Children (1-13 years old) | Male | Hypermanganesemia with dystonia 1 | | details | Blood | Detected and Quantified | 0.963-3.830 uM | Children (1-13 years old) | Both | Hypermanganesemia with dystonia 2 | | details | Blood | Detected and Quantified | 0.011 +/- 0 .004 uM | Elderly (>65 years old) | Both | Alzheimer's disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0346 +/- 0.0182 uM | Adult (>18 years old) | Not Specified | control | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0400 +/- 0.0273 uM | Adult (>18 years old) | Not Specified | amyotrophic lateral sclerosis | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0400 +/- 0.0255 uM | Adult (>18 years old) | Not Specified | amyotrophic lateral sclerosis (classic) | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0419 +/- 0.0291 uM | Adult (>18 years old) | Not Specified | Amyotrophic lateral sclerosis (bulbar onset) | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0328 +/- 0.0164 uM | Adult (>18 years old) | Not Specified | Alzheimer's disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0218 +/- 0.00546 uM | Adult (>18 years old) | Not Specified | Alzheimer's disease (early-onset) | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0382 +/- 0.0182 uM | Adult (>18 years old) | Not Specified | Alzheimer's disease (late-onset) | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0546 +/- 0.0382 uM | Adult (>18 years old) | Not Specified | Parkinson's disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0146 +/- 0.0146 uM | Elderly (>65 years old) | Both | Alzheimer's disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 14.6 +/- 13.7 uM | Elderly (>65 years old) | Not Specified | Alzheimer's disease | | details | Saliva | Detected and Quantified | 0.910 +/- 0.546 uM | Adult (>18 years old) | Not Specified | Oral squamous cell carcinoma | | details | Saliva | Detected and Quantified | 1.0921 +/- 0.546 uM | Adult (>18 years old) | Not Specified | Oral squamous cell carcinoma | | details | Saliva | Detected and Quantified | 1.456 +/- 0.546 uM | Adult (>18 years old) | Not Specified | Oral squamous cell carcinoma | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Multiple sclerosis |
---|
- Forte G, Visconti A, Santucci S, Ghazaryan A, Figa-Talamanca L, Cannoni S, Bocca B, Pino A, Violante N, Alimonti A, Salvetti M, Ristori G: Quantification of chemical elements in blood of patients affected by multiple sclerosis. Ann Ist Super Sanita. 2005;41(2):213-6. [PubMed:16244395 ]
| Parkinson's disease |
---|
- Forte G, Alimonti A, Pino A, Stanzione P, Brescianini S, Brusa L, Sancesario G, Violante N, Bocca B: Metals and oxidative stress in patients with Parkinson's disease. Ann Ist Super Sanita. 2005;41(2):189-95. [PubMed:16244392 ]
- Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2. [PubMed:21292280 ]
| Hypermanganesemia with dystonia 1 |
---|
- Tuschl K, Mills PB, Parsons H, Malone M, Fowler D, Bitner-Glindzicz M, Clayton PT: Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia--a new metabolic disorder. J Inherit Metab Dis. 2008 Apr;31(2):151-63. doi: 10.1007/s10545-008-0813-1. Epub 2008 Apr 4. [PubMed:18392750 ]
- Mukhtiar K, Ibrahim S, Tuschl K, Mills P: Hypermanganesemia with Dystonia, Polycythemia and Cirrhosis (HMDPC) due to mutation in the SLC30A10 gene. Brain Dev. 2016 Oct;38(9):862-5. doi: 10.1016/j.braindev.2016.04.005. Epub 2016 Apr 23. [PubMed:27117033 ]
- Gospe SM Jr, Caruso RD, Clegg MS, Keen CL, Pimstone NR, Ducore JM, Gettner SS, Kreutzer RA: Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis. Arch Dis Child. 2000 Nov;83(5):439-42. [PubMed:11040156 ]
| Hypermanganesemia with dystonia 2 |
---|
- Tuschl K, Meyer E, Valdivia LE, Zhao N, Dadswell C, Abdul-Sada A, Hung CY, Simpson MA, Chong WK, Jacques TS, Woltjer RL, Eaton S, Gregory A, Sanford L, Kara E, Houlden H, Cuno SM, Prokisch H, Valletta L, Tiranti V, Younis R, Maher ER, Spencer J, Straatman-Iwanowska A, Gissen P, Selim LA, Pintos-Morell G, Coroleu-Lletget W, Mohammad SS, Yoganathan S, Dale RC, Thomas M, Rihel J, Bodamer OA, Enns CA, Hayflick SJ, Clayton PT, Mills PB, Kurian MA, Wilson SW: Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia. Nat Commun. 2016 May 27;7:11601. doi: 10.1038/ncomms11601. [PubMed:27231142 ]
| Alzheimer's disease |
---|
- Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88. [PubMed:9720975 ]
- Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203. [PubMed:16244393 ]
- Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2. [PubMed:21292280 ]
| Amyotrophic lateral sclerosis |
---|
- Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2. [PubMed:21292280 ]
|
|
---|
Associated OMIM IDs | - 126200 (Multiple sclerosis)
- 168600 (Parkinson's disease)
- 613280 (Hypermanganesemia with dystonia 1)
- 617013 (Hypermanganesemia with dystonia 2)
- 104300 (Alzheimer's disease)
- 105400 (Amyotrophic lateral sclerosis)
|
---|
External Links |
---|
DrugBank ID | DB06757 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB031005 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 25916 |
---|
KEGG Compound ID | C19610 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Manganese |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 27854 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 29035 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | MDB00000315 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Ikeda S, Sera Y, Yoshida M, Ohshiro H, Uchino S, Oka Y, Lee KJ, Kotera A: Manganese deposits in patients with biliary atresia after hepatic porto-enterostomy. J Pediatr Surg. 2000 Mar;35(3):450-3. [PubMed:10726687 ]
- Greger JL: Nutrition versus toxicology of manganese in humans: evaluation of potential biomarkers. Neurotoxicology. 1999 Apr-Jun;20(2-3):205-12. [PubMed:10385884 ]
- Lander F, Kristiansen J, Lauritsen JM: Manganese exposure in foundry furnacemen and scrap recycling workers. Int Arch Occup Environ Health. 1999 Nov;72(8):546-50. [PubMed:10592008 ]
- Mizoguchi N, Nishimura Y, Ono H, Sakura N: Manganese elevations in blood of children with congenital portosystemic shunts. Eur J Pediatr. 2001 Apr;160(4):247-50. [PubMed:11317649 ]
- Woolf A, Wright R, Amarasiriwardena C, Bellinger D: A child with chronic manganese exposure from drinking water. Environ Health Perspect. 2002 Jun;110(6):613-6. [PubMed:12055054 ]
- Ikeda S, Yamaguchi Y, Sera Y, Ohshiro H, Uchino S, Yamashita Y, Ogawa M: Manganese deposition in the globus pallidus in patients with biliary atresia. Transplantation. 2000 Jun 15;69(11):2339-43. [PubMed:10868637 ]
- Wardle CA, Forbes A, Roberts NB, Jawhari AV, Shenkin A: Hypermanganesemia in long-term intravenous nutrition and chronic liver disease. JPEN J Parenter Enteral Nutr. 1999 Nov-Dec;23(6):350-5. [PubMed:10574484 ]
- Mergler D, Baldwin M, Belanger S, Larribe F, Beuter A, Bowler R, Panisset M, Edwards R, de Geoffroy A, Sassine MP, Hudnell K: Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology. 1999 Apr-Jun;20(2-3):327-42. [PubMed:10385894 ]
- Butterworth RF: Hepatic encephalopathy. Alcohol Res Health. 2003;27(3):240-6. [PubMed:15535452 ]
- Herynek V, Babis M, Trunecka P, Filip K, Vymazal J, Dezortova M, Hajek M: Chronic liver disease: relaxometry in the brain after liver transplantation. MAGMA. 2001 Mar;12(1):10-5. [PubMed:11255087 ]
- Miranda M, Caballero L: [Chronic hepatic encephalopathy: the role of high serum manganese levels and its relation with basal ganglia lesions in nuclear magnetic resonance of the brain. Clinical case]. Rev Med Chil. 2001 Sep;129(9):1051-5. [PubMed:11725469 ]
- Barceloux DG: Manganese. J Toxicol Clin Toxicol. 1999;37(2):293-307. [PubMed:10382563 ]
- Bader M, Dietz MC, Ihrig A, Triebig G: Biomonitoring of manganese in blood, urine and axillary hair following low-dose exposure during the manufacture of dry cell batteries. Int Arch Occup Environ Health. 1999 Nov;72(8):521-7. [PubMed:10592004 ]
- Kao HJ, Chen WH, Liu JS: Rapid progression of parkinsonism associated with an increase of blood manganese. Kaohsiung J Med Sci. 1999 May;15(5):297-301. [PubMed:10375873 ]
- Melo TM, Larsen C, White LR, Aasly J, Sjobakk TE, Flaten TP, Sonnewald U, Syversen T: Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis. Biol Trace Elem Res. 2003 Summer;93(1-3):1-8. [PubMed:12835484 ]
- Lees-Haley PR, Rohling ML, Langhinrichsen-Rohling J: A meta-analysis of the neuropsychological effects of occupational exposure to manganese. Clin Neuropsychol. 2006 Feb;20(1):90-107. [PubMed:16393922 ]
- Sadek AH, Rauch R, Schulz PE: Parkinsonism due to manganism in a welder. Int J Toxicol. 2003 Sep-Oct;22(5):393-401. [PubMed:14555414 ]
- Wang X, Li GJ, Zheng W: Upregulation of DMT1 expression in choroidal epithelia of the blood-CSF barrier following manganese exposure in vitro. Brain Res. 2006 Jun 30;1097(1):1-10. Epub 2006 May 26. [PubMed:16729984 ]
- Takeda A: Manganese action in brain function. Brain Res Brain Res Rev. 2003 Jan;41(1):79-87. [PubMed:12505649 ]
- Baldwin M, Mergler D, Larribe F, Belanger S, Tardif R, Bilodeau L, Hudnell K: Bioindicator and exposure data for a population based study of manganese. Neurotoxicology. 1999 Apr-Jun;20(2-3):343-53. [PubMed:10385895 ]
|
---|